Life Insurance Quotes

Study shows drug may treat lung cancer

11/11/11

A new drug that controls genes has been tested and is showing signs that it may help certain patients with advanced lung cancer.

The study is generating motivation in the battle against cancer, showing that when chemotherapy fails cancer patients, epigenetic drugs may work.The drug controls the way information from genes is utilized to create proteins and other products.

"This is a groundbreaking study, showing that by modifying the epigenetics of a cancer cell we can get real responses in lung cancer," said Jeffrey A. Engleman, director of thoracic oncology at Massachusetts General Hospital in Boston. "And getting real responses in lung cancer is actually quite difficult, so we take special notice of therapies that can do this."

Forty-five cancer patients were recruited for the study. All of the recruits had non-small-cell lung cancer, the leading cancer killer in the United States. Eleven of the patients dropped out of the study before the end, but among the remaining recruits, researchers reported seeing increases in average survival for those who completed a full cycle of the treatment.

According to the American Cancer Society, there were more than 373,000 Americans diagnosed with lung and bronchus cancer in 2008, an alarming statistic that suggests why individuals should invest in life insurance at a young age.

Talk to an Advisor

A licensed insurance advisor can explain your options and help you choose the right life insurance for your needs.

Call: 1-800-823-4852

Chat: Live Advisor Chat

Sm

A few of the carriers we quote